NATCO Pharma submits investor presentation
Date: 19-08-2026Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, NATCO Pharma has informed that it enclosed the Investor Presentation.
The above information is a part of company’s filings submitted to BSE.